Acerand Therapeutics
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A neuroscience biotech developing innovative small molecule therapies for CNS disorders with high unmet medical need.
Neuroscience
Technology Platform
An integrated CNS drug discovery platform combining novel target validation, blood-brain barrier penetration modeling, and medicinal chemistry.
Opportunities
Opportunity to address devastating CNS disorders with no effective treatments, potentially leading to breakthrough therapy designation and premium partnerships.
Risk Factors
Extreme biological complexity and high clinical failure rates in neuroscience pose existential development risks.
Competitive Landscape
Competes in the high-risk neuroscience field where many large pharma programs have failed, but where successful innovation commands high value.